MedPath

COPD: A Multi-center Supervised Tele-rehabilitation Study

Not Applicable
Not yet recruiting
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Behavioral: center-based traditional rehabilitation group
Behavioral: home-based telerehabilitation group
Registration Number
NCT06085261
Lead Sponsor
China-Japan Friendship Hospital
Brief Summary

Chronic obstructive pulmonary disease(COPD) patients could benefit from pulmonary rehabilitation(PR) in better managing of the disease and its symptoms and in avoiding future relapses and hospitalizations. However, due to a large number of drop outs from PR, lack of professionals, and the (Corona Virus Disease 2019) COVID-19 epidemic, the PR has been underutilized, leading to a need for investigation of updated forms. The study aims to investigate the effects of a home-based PR program using minimal accessories, facilitated with wearable activity trackers and smartphones.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
360
Inclusion Criteria

Not provided

Exclusion Criteria
  1. Certain comorbidities (e.g. unstable coronary complications)
  2. Severe cognitive disabilities (e.g. dementia)
  3. Inability to cope with the program because of severe hearing or visual disorder.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
center-based traditional rehabilitationcenter-based traditional rehabilitation groupParticipants will undertake an aerobic, strength and respiratory training program of similar intensity and duration to the home-based program, at their site of recruitment.
home-based telerehabilitationhome-based telerehabilitation groupRemotely supervised telerehabilitation at home will be conducted for 8 weeks, comprising lower limb aerobic training, individualized strength training and respiratory training exercises.
Primary Outcome Measures
NameTimeMethod
6-minute walk distance (6MWD)8 weeks; 20 weeks

6-minute walk distance

Secondary Outcome Measures
NameTimeMethod
pulmonary function8 weeks; 20 weeks

diffusing capacity of the lung for carbon monoxide (DLCO) \[velocity\]

Short Physical Performance Battery(SPPB)8 weeks; 20 weeks

Test for health-related physical performance

COPD assessment test(CAT)8 weeks; 20 weeks

It is a self-reported quality of life questionnaire ranging from 0-10 score, higher scores mean a worse outcome.

modified British medical research council(mMRC)8 weeks; 20 weeks

It is a self-reported symptom questionnaire ranging from 0-4 score, higher scores mean a worse outcome.

Respiratory muscle strength8 weeks; 20 weeks

maximum inspiratory pressure(MIP), maximum expiratory pressure(MEP)

St. George's Respiratory Questionnaire (SGRQ)8 weeks; 20 weeks

It is a self-reported symptom questionnaire ranging from 0-100 score, higher scores mean a worse outcome.

Hospital Anxiety and Depression Scale(HADS)8 weeks; 20 weeks

It is a self-reported psychological status questionnaire ranging from 0-42 score, higher scores mean a worse outcome.

Trial Locations

Locations (1)

China-Japan Friendship hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath